Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

This study is being performed to compare the systemic pharmacokinetic profiles of T4032 and Lumigan 0.01% given that T4032 has a different formulation (in terms of excipients) from the reference product.

Inclusion Criteria:Informed consent signed and datedHealthy participants who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the studyParticipants with no ocular symptomsExclusion Criteria:History of ocular trauma, infection, or inflammation within the last 3 monthsPresence of an ocular pathology such as blepharitis, conjunctivitis, uveitis, or any other ocular infection or inflammationIOP <10 mmHg or >21 mmHg